Recent Updates
Recently added Catalysts
ESPR

Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference

Key Takeaway: ANN ARBOR, Mich., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer, Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH focused panel, in addition to one-on-one investor meetings with other members of management, at the

Full Press Release Details

ANN ARBOR, Mich., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer, Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH focused panel, in addition to one-on-one investor meetings with other members of management, at the upcoming Cowen 42nd Annual Healthcare Conference on Tuesday, March 8, 2022.
Event: Cowen 42 nd Annual Healthcare Conference
Date: Tuesday, March 8, 2022
Format: Virtual Panel and 1:1 Meetings
Panel: Cardiometabolic/NASH
Time: 12:50 p.m. ET
Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.
Esperion Therapeutics

Tags

Last updated: Feb 24, 2022